<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Genet Genomic Med</journal-id><journal-id journal-id-type="iso-abbrev">Mol Genet Genomic Med</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2324-9269</journal-id><journal-id journal-id-type="publisher-id">MGG3</journal-id><journal-title-group><journal-title>Molecular Genetics &#x00026; Genomic Medicine</journal-title></journal-title-group><issn pub-type="epub">2324-9269</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27652281</article-id><article-id pub-id-type="pmc">5023939</article-id><article-id pub-id-type="doi">10.1002/mgg3.230</article-id><article-id pub-id-type="publisher-id">MGG3230</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>
<italic><styled-content style="fixed-case">ADGRL</styled-content>3 (<styled-content style="fixed-case">LPHN</styled-content>3)</italic> variants are associated with a refined phenotype of <styled-content style="fixed-case">ADHD</styled-content> in the <styled-content style="fixed-case">MTA</styled-content> study</article-title><alt-title alt-title-type="left-running-head">M. T. Acosta <italic>et&#x000a0;al</italic>.</alt-title></title-group><contrib-group><contrib id="mgg3230-cr-0001" contrib-type="author"><name><surname>Acosta</surname><given-names>Maria T.</given-names></name><xref ref-type="aff" rid="mgg3230-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="mgg3230-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="mgg3230-cr-0002" contrib-type="author"><name><surname>Swanson</surname><given-names>James</given-names></name><xref ref-type="aff" rid="mgg3230-aff-0003">
<sup>3</sup>
</xref><xref ref-type="aff" rid="mgg3230-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="mgg3230-cr-0003" contrib-type="author"><name><surname>Stehli</surname><given-names>Annamarie</given-names></name><xref ref-type="aff" rid="mgg3230-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="mgg3230-cr-0004" contrib-type="author"><name><surname>Molina</surname><given-names>Brooke S. G.</given-names></name><xref ref-type="aff" rid="mgg3230-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="mgg3230-cr-0005" contrib-type="author"><collab collab-type="authors">the MTA Team</collab></contrib><contrib id="mgg3230-cr-0006" contrib-type="author"><name><surname>Martinez</surname><given-names>Ariel F.</given-names></name><xref ref-type="aff" rid="mgg3230-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mgg3230-cr-0007" contrib-type="author" corresp="yes"><name><surname>Arcos&#x02010;Burgos</surname><given-names>Mauricio</given-names></name><address><email>Mauricio.Arcos-Burgos@anu.edu.au</email></address><xref ref-type="aff" rid="mgg3230-aff-0006">
<sup>6</sup>
</xref></contrib><contrib id="mgg3230-cr-0008" contrib-type="author" corresp="yes"><name><surname>Muenke</surname><given-names>Maximilian</given-names></name><address><email>mamuenke@mail.nih.gov</email></address><xref ref-type="aff" rid="mgg3230-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="mgg3230-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">Medical Genetics Branch</named-content><institution>National Human Genome Research Institute</institution><institution>National Institutes of Health</institution><named-content content-type="city">Bethesda</named-content><named-content content-type="country-part">Maryland</named-content></aff><aff id="mgg3230-aff-0002"><label><sup>2</sup></label><named-content content-type="organisation-division">Department of Pediatric and Neurology</named-content><institution>George Washington University</institution><institution>Children's National Medical Center</institution><named-content content-type="city">Washington</named-content><named-content content-type="country-part">District of Columbia</named-content></aff><aff id="mgg3230-aff-0003"><label><sup>3</sup></label><named-content content-type="organisation-division">Department of Psychiatry</named-content><institution>Florida International University</institution><named-content content-type="city">Miami</named-content><named-content content-type="country-part">Florida</named-content></aff><aff id="mgg3230-aff-0004"><label><sup>4</sup></label><named-content content-type="organisation-division">Department of Pediatrics</named-content><institution>University of California at Irvine</institution><named-content content-type="city">Irvine</named-content><named-content content-type="country-part">California</named-content></aff><aff id="mgg3230-aff-0005"><label><sup>5</sup></label><named-content content-type="organisation-division">Departments of Psychiatry and Psychology</named-content><institution>University of Pittsburgh</institution><named-content content-type="city">Pittsburgh</named-content><named-content content-type="country-part">Pennsylvania</named-content></aff><aff id="mgg3230-aff-0006"><label><sup>6</sup></label><named-content content-type="organisation-division">Genomics and Predictive Medicine</named-content><institution>Genome Biology Department</institution><institution>John Curtin School of Medical Research</institution><institution>ANU College of Medicine, Biology and Environment</institution><institution>The Australian National University</institution><named-content content-type="city">Canberra</named-content><named-content content-type="country-part">ACT</named-content><country country="AU">Australia</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Mauricio Arcos&#x02010;Burgos, Genomics and Predictive Medicine, Genome Biology Department, John Curtin School of Medical Research, ANU College of Medicine, Biology and Environment, The Australian National University, Building 131 Garran Road, Canberra, ACT 2600 Australia. Tel: +61 2 61259396; Fax: 61&#x02010;261252499; E&#x02010;mail: <email>Mauricio.Arcos-Burgos@anu.edu.au</email><break/>
and<break/>
Maximilian Muenke, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, 35 Convent Drive, MSC 3717, Building 35, Room 1B203, Bethesda, MD 20892&#x02010;3717. Tel: 301 402 8167; Fax: 301 496 7184; E&#x02010;mail: <email>mamuenke@mail.nih.gov</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>7</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2016</year></pub-date><volume>4</volume><issue>5</issue><issue-id pub-id-type="doi">10.1002/mgg3.2016.4.issue-5</issue-id><fpage>540</fpage><lpage>547</lpage><history><date date-type="received"><day>18</day><month>3</month><year>2016</year></date><date date-type="rev-recd"><day>19</day><month>5</month><year>2016</year></date><date date-type="accepted"><day>23</day><month>5</month><year>2016</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 Wiley Periodicals, Inc. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2016 The Authors. <italic>Molecular Genetics &#x00026; Genomic Medicine</italic> published by Wiley Periodicals, Inc.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:MGG3-4-540.pdf"/><abstract id="mgg3230-abs-0001"><title>Abstract</title><sec id="mgg3230-sec-0001"><title>Background</title><p>
<styled-content style="fixed-case">ADHD</styled-content> is the most common neuropsychiatric condition affecting individuals of all ages. Long&#x02010;term outcomes of affected individuals and association with severe comorbidities as <styled-content style="fixed-case">SUD</styled-content> or conduct disorders are the main concern. Genetic associations have been extensively described. Multiple studies show that intronic variants harbored in the <italic><styled-content style="fixed-case">ADGRL</styled-content>3 (<styled-content style="fixed-case">LPHN</styled-content>3)</italic> gene are associated with <styled-content style="fixed-case">ADHD</styled-content>, especially associated with poor outcomes.</p></sec><sec id="mgg3230-sec-0002"><title>Methods</title><p>In this study, we evaluated this association in the Multimodal Treatment Study of children with <styled-content style="fixed-case">ADHD</styled-content> (<styled-content style="fixed-case">MTA</styled-content>), initiated as a 14&#x02010;month randomized clinical trial of 579 children diagnosed with <styled-content style="fixed-case">DSM</styled-content>&#x02010;<styled-content style="fixed-case">IV ADHD</styled-content>&#x02010;Combined Type (<styled-content style="fixed-case">ADHD</styled-content>&#x02010;C), that transitioned to a 16&#x02010;year prospective observational follow&#x02010;up, and 289 classmates added at the 2&#x02010;year assessment to serve as a local normative comparison group (<styled-content style="fixed-case">LNCG</styled-content>). Diagnostic evaluations at entry were based on the Diagnostic Interview Schedule for Children&#x02010;Parent (<styled-content style="fixed-case">DISC</styled-content>&#x02010;P), which was repeated at several points over the years. For an add&#x02010;on genetic study, blood samples were collected from 232 in the <styled-content style="fixed-case">MTA</styled-content> group and 139 in the <styled-content style="fixed-case">LNCG</styled-content>.</p></sec><sec id="mgg3230-sec-0003"><title>Results</title><p>For the 205 <styled-content style="fixed-case">MTA</styled-content> participants, 14.6% retained the <styled-content style="fixed-case">DISC</styled-content>&#x02010;P diagnosis of <styled-content style="fixed-case">ADHD</styled-content>&#x02010;C in adolescence. For 127 <styled-content style="fixed-case">LNCG</styled-content> participants, 88.2% remained undiagnosed by the <styled-content style="fixed-case">DISC</styled-content>&#x02010;P. We genotyped 15 polymorphic <styled-content style="fixed-case">SNP</styled-content> markers harbored in the <italic><styled-content style="fixed-case">ADGRL</styled-content>3</italic> gene, and compared allele frequencies for the 30 cases with continued diagnosis of <styled-content style="fixed-case">ADHD</styled-content>&#x02010;C in adolescence to the other participants. Replication of the association of rs2345039 <italic><styled-content style="fixed-case">ADGRL</styled-content>3</italic> variant was observed (<italic>P</italic> value&#x000a0;=&#x000a0;0.004, <styled-content style="fixed-case">FDR</styled-content> corrected&#x000a0;=&#x000a0;0.03; Odds ratio&#x000a0;=&#x000a0;2.25, upper <styled-content style="fixed-case">CI</styled-content> 1.28&#x02013;3.97).</p></sec><sec id="mgg3230-sec-0004"><title>Conclusion</title><p>The detection of susceptibility conferred by <italic><styled-content style="fixed-case">ADGRL</styled-content>3</italic> variants in the extreme phenotype of continued diagnosis of <styled-content style="fixed-case">ADHD</styled-content>&#x02010;C from childhood to adolescence provides additional support that the association of <italic><styled-content style="fixed-case">ADGRL</styled-content>3</italic> and <styled-content style="fixed-case">ADHD</styled-content> is not spurious. Exploring genetic effects in longitudinal cohorts, in which refined, age&#x02010;dependent phenotypes are documented, is crucial to understand the natural history of <styled-content style="fixed-case">ADHD</styled-content>.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="mgg3230-kwd-0001"><italic><styled-content style="fixed-case">ADGRL</styled-content>3</italic></kwd><kwd id="mgg3230-kwd-0002"><styled-content style="fixed-case">ADHD</styled-content></kwd><kwd id="mgg3230-kwd-0003">genetics</kwd><kwd id="mgg3230-kwd-0004"><italic><styled-content style="fixed-case">LPHN</styled-content>3</italic></kwd><kwd id="mgg3230-kwd-0005"><styled-content style="fixed-case">MTA</styled-content></kwd></kwd-group><counts><fig-count count="1"/><table-count count="3"/><page-count count="8"/><word-count count="5827"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>mgg3230</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2016</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:15.09.2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="mgg3230-sec-0005"><title>Introduction</title><p>Family, twin, and case&#x02013;control&#x02010;based linkage and association studies indicate that genetics play a crucial role in shaping susceptibility to both ADHD and disruptive behaviors (Arcos&#x02010;Burgos et&#x000a0;al. <xref rid="mgg3230-bib-0005" ref-type="ref">2012</xref>; Jain et&#x000a0;al. <xref rid="mgg3230-bib-0017" ref-type="ref">2012</xref>). Using genome wide data, we found evidence of linkage of ADHD to chromosomes 4q13.2, 5q33.3, 8q11.23, 11q22, and 17p11 (Arcos&#x02010;Burgos et&#x000a0;al. <xref rid="mgg3230-bib-0003" ref-type="ref">2004</xref>). Furthermore, linkage and association analyses revealed not only cosegregation between ADHD and disruptive behaviors but also the existence of common signals of linkage to several loci (Jain et&#x000a0;al. <xref rid="mgg3230-bib-0016" ref-type="ref">2007</xref>). Reverse genetics allowed us to identify variants in the <italic>adhesion G&#x02010;protein&#x02010;coupled receptor L3 gene (ADGRL3,</italic> also known as <italic>latrophilin 3</italic> or <italic>LPHN3)</italic> (Accession number NC_000004.12, GRCh38.p2) (OMIM:616417) at 4q13.2 that predisposes to ADHD and disruptive behaviors (Arcos&#x02010;Burgos et&#x000a0;al. <xref rid="mgg3230-bib-0004" ref-type="ref">2010</xref>; Acosta et&#x000a0;al. <xref rid="mgg3230-bib-0001" ref-type="ref">2011</xref>; Domene et&#x000a0;al. <xref rid="mgg3230-bib-0009" ref-type="ref">2011</xref>; Martinez et&#x000a0;al. <xref rid="mgg3230-bib-0023" ref-type="ref">2011</xref>; Ribases et&#x000a0;al. <xref rid="mgg3230-bib-0028" ref-type="ref">2011</xref>; Jain et&#x000a0;al. <xref rid="mgg3230-bib-0017" ref-type="ref">2012</xref>). Using cohorts of thousands of individuals from Colombia, Germany, Norway, Spain, and the United States, we found a significant homogeneous genetic effect of <italic>ADGRL3</italic> variants predisposing to ADHD in children, adolescents, and adults, and predicting the response to stimulant medication, (Arcos&#x02010;Burgos et&#x000a0;al. <xref rid="mgg3230-bib-0004" ref-type="ref">2010</xref>, <xref rid="mgg3230-bib-0005" ref-type="ref">2012</xref>; Ribases et&#x000a0;al. <xref rid="mgg3230-bib-0028" ref-type="ref">2011</xref>; Fallgatter et&#x000a0;al. <xref rid="mgg3230-bib-0010" ref-type="ref">2013</xref>). These results were independently replicated in four additional pharmacogenetic studies from Canada, Brazil, and Korea (Choudhry et&#x000a0;al. <xref rid="mgg3230-bib-0008" ref-type="ref">2012</xref>; Labbe et&#x000a0;al. <xref rid="mgg3230-bib-0019" ref-type="ref">2012</xref>; Bruxel et&#x000a0;al. <xref rid="mgg3230-bib-0007" ref-type="ref">2015</xref>; Hwang et&#x000a0;al. <xref rid="mgg3230-bib-0015" ref-type="ref">2015</xref>).</p><p>ADGRL3 is a member of the latrophilin subfamily of G&#x02010;protein&#x02010;coupled receptors (GPCRs) (Martinez et&#x000a0;al. <xref rid="mgg3230-bib-0023" ref-type="ref">2011</xref>). Latrophilin ADGRL1 and ADGRL2 serve as receptors for alpha&#x02010;latrotoxin, a component of the venom of the black widow spider (<italic>Latrodectus mactans</italic>) (Martinez et&#x000a0;al. <xref rid="mgg3230-bib-0023" ref-type="ref">2011</xref>). We showed that ADGRL3 is only expressed almost exclusively in the brain and mostly is highly expressed in regions neurophysiologically associated with the pathology of ADHD (Arcos&#x02010;Burgos et&#x000a0;al. <xref rid="mgg3230-bib-0004" ref-type="ref">2010</xref>). Recently, the identification of the fibronectin family of leucine&#x02010;rich repeat transmembrane protein 3 (FLRT3) was identified as an endogenous postsynaptic ligands for ADGRL3, facilitated the identification of a high&#x02010;affinity trans interaction between the ADGRL3 ectodomain with its ligand, FLRT3 (O'Sullivan et&#x000a0;al. <xref rid="mgg3230-bib-0027" ref-type="ref">2012</xref>) and interfering with this interaction reduces excitatory synapse density in cultured neurons and decreases afferent input strength and dendritic spine number in dentate granule cells. This suggests that the ADGRL3 and its ligand&#x02010; FLRT3 partnership plays an important role in glutamatergic synapse development (O'Sullivan et&#x000a0;al. <xref rid="mgg3230-bib-0027" ref-type="ref">2012</xref>). We found that gene ontology pathways involved in axon guidance, regulation of synaptic transmission, and regulation of transmission of nerve impulse, are overrepresented when <italic>ADGRL3</italic> variants associated with ADHD are tested. In agreement with our results, data from a mutant knockout mouse model null for the <italic>Adgrl3,</italic> gene as well as the loss of function of the ortholog <italic>adgrl3.1</italic> during zebrafish development, also support the implication of <italic>ADGRL3</italic> in ADHD pathophysiology (Arcos&#x02010;Burgos et&#x000a0;al. <xref rid="mgg3230-bib-0005" ref-type="ref">2012</xref>; Lange et&#x000a0;al. <xref rid="mgg3230-bib-0020" ref-type="ref">2012</xref>; Wallis et&#x000a0;al. <xref rid="mgg3230-bib-0032" ref-type="ref">2012</xref>).</p><p>In this study, we explored the association of <italic>ADGRL3</italic> variants with ADHD in the Multimodal Treatment Study of children with ADHD (MTA). The MTA study was initiated as a 14&#x02010;month randomized clinical trial of 579 children diagnosed with DSM&#x02010;IV ADHD&#x02010;Combined Type (ADHD&#x02010;C, between 7.0 and 9.9&#x000a0;years of age) that transitioned to a 16&#x02010;year prospective observational follow&#x02010;up, and 289 classmates added at the 2&#x02010;year assessment to serve as a local normative comparison group (LNCG). Outcomes at the end of the randomized clinical trial and at follow&#x02010;up in childhood and adolescence have been reported (1999; Jensen et&#x000a0;al. <xref rid="mgg3230-bib-0018" ref-type="ref">2007</xref>; Molina et&#x000a0;al. <xref rid="mgg3230-bib-0026" ref-type="ref">2013</xref>, <xref rid="mgg3230-bib-0025" ref-type="ref">2009</xref>; Molina and Pelham <xref rid="mgg3230-bib-0024" ref-type="ref">2003</xref>). Exploring genetic association in longitudinal studies, in which age&#x02010;dependent refined phenotypes are ascertained prospectively, is crucial to better understand genetic effects on the natural history of ADHD (Faraone et&#x000a0;al. <xref rid="mgg3230-bib-0011" ref-type="ref">2006</xref>; Franke et&#x000a0;al. <xref rid="mgg3230-bib-0012" ref-type="ref">2012</xref>).</p></sec><sec id="mgg3230-sec-0006"><title>Material and Methods</title><sec id="mgg3230-sec-0007"><title>Ethical complience</title><p>The MTA study is a cooperative treatment study performed by six independent research teams in collaboration with the Division of Services and Intervention Research, National Institute of Mental Health, and the Office of Special Education Programs, U.S. Department of Education, Washington, DC (The MTA Cooperative Group <xref rid="mgg3230-bib-0030" ref-type="ref">1999</xref>). Research was conducted in accordance with the ethical guidelines of both local institutional review boards and the National Institutes of Health Office for Protection From Research Risks, Bethesda, MD.</p></sec><sec id="mgg3230-sec-0008"><title>Subjects</title><p>The MTA was designed to evaluate long&#x02010;term effects of treatments for ADHD in a 14&#x02010;month randomized controlled trial of 579 children assigned to a four treatment groups &#x02013; medication management, behavior modification, their combination, and treatment as usual in community care. After the 14&#x02010;month treatment&#x02010;by&#x02010;protocol phase, the MTA continued as a naturalistic follow&#x02010;up, in which self&#x02010;selected use of psychoactive medication was monitored. A LNCG of 289 randomly selected classmates group&#x02010;matched for grade and sex was added when the ADHD participants were between 9 and 12&#x000a0;years of age. The outcomes in childhood (14, 24, 36&#x000a0;months after baseline), and adolescence (6 and 8&#x000a0;years after baseline) have been reported (1999; Jensen et&#x000a0;al. <xref rid="mgg3230-bib-0018" ref-type="ref">2007</xref>; Molina et&#x000a0;al. <xref rid="mgg3230-bib-0026" ref-type="ref">2013</xref>, <xref rid="mgg3230-bib-0025" ref-type="ref">2009</xref>; Molina and Pelham <xref rid="mgg3230-bib-0024" ref-type="ref">2003</xref>). In the MTA, the participants were diagnosed in childhood based on the DSM&#x02010;IV criteria for ADHD subtypes (hyperactive/impulsive, inattentive, and combined) using the Diagnostic Interview Schedule for Children&#x02010;Parent Version (DISC&#x02010;P), supplemented with teacher report of symptoms. The DISC&#x02010;P was administered at entry (in childhood) and at each of the prospective follow&#x02010;up assessments, including the 6&#x02010;year follow&#x02010;up when the participants were between 13.0 and 15.9&#x000a0;years of age in thus in adolescence.</p><p>Clinical observations and longitudinal studies document that symptom presence and severity decrease over time in some children with ADHD, resulting in decreased diagnosis with age (Faraone et&#x000a0;al. <xref rid="mgg3230-bib-0011" ref-type="ref">2006</xref>; Franke et&#x000a0;al. <xref rid="mgg3230-bib-0012" ref-type="ref">2012</xref>). In the prospective follow&#x02010;up of the MTA, a refined phenotype based on DSM&#x02010;IV diagnostic persistence was established by determining the cases that maintained the parent&#x02010;reported symptoms of the disorder in adolescence (persistent ADHD&#x02010;C). We used this refined phenotype to study the association of the <italic>ADGRL3</italic> genetic variants with ADHD. We hypothesized that those with persistence of the symptoms that qualified them for entry into the study as children would be more likely as adolescents to have <italic>ADGRL3</italic> genetic susceptibility compared to those whose diagnostic subtype shifted or disappeared. This highly vulnerable subgroup may also be more susceptible to poor outcomes as described elsewhere (Arcos&#x02010;Burgos et&#x000a0;al. <xref rid="mgg3230-bib-0004" ref-type="ref">2010</xref>).</p></sec><sec id="mgg3230-sec-0009"><title>Genotyping</title><p>Genomic DNA was extracted from whole blood using the QIAamp DNA Blood Maxi Kit (QIAGEN, Germantown, MD). Samples were subjected to whole&#x02010;exome genotyping using the Illumina<sup>&#x000ae;</sup> HumanExome BeadChip&#x02010;12v1_A, which covers putative functional exonic variants selected from over 12,000 individuals. The exonic content consists of &#x0003e;250,000 markers representing diverse populations &#x02013; including European, African, Chinese, and Hispanic individuals &#x02013; and a range of common conditions, such as type 2 diabetes, cancer, metabolic, and psychiatric disorders. Four open controls per 96&#x02010;well&#x02010;plate were used for internal quality control, including two positive and two blank controls. Duplicates assessed data quality across all plates. Genotyping from nonmatching duplicates was dropped. Only data generated by SNP assays that were successfully genotyped on at least 90% of samples were analyzed. In addition, we genotyped the <italic>ADGRL3</italic> (Accession number NC_000004.12, GRCh38.p2) susceptibility haplotype variants rs2345039, rs6551665, and rs1947274 previously reported (Arcos&#x02010;Burgos et&#x000a0;al. <xref rid="mgg3230-bib-0004" ref-type="ref">2010</xref>), which were not represented in the exome chip. Briefly, genotyping was performed using TaqMan<sup>&#x000ae;</sup> SNP Genotyping Assays (Thermo Fisher Scientific, Grand Island, NY). Allelic discrimination real&#x02010;time PCR reactions were performed in a 384&#x02010;well&#x02010;plate format in duplicate for each individual sample according to manufacturer's instructions. Briefly, 20&#x000a0;ng of genomic DNA was mixed with 2.5&#x000a0;&#x003bc;L of 2&#x000d7; TaqMan<sup>&#x000ae;</sup> Universal PCR Master Mix and 0.25&#x000a0;&#x003bc;L of 20&#x000d7; SNP Genotyping Assay in a total volume of 5&#x000a0;&#x003bc;L per well. Assays were run in an ABI 7900HT Fast Real&#x02010;Time PCR System (Thermo Fisher Scientific, Grand Island, NY). Allele calling was determined by end&#x02010;point fluorescent signal analysis using the ABI's SDS2.3 software (SABiosciences &#x02010; QIAGEN Inc., 27220, Turnberry Lane, Valencia, CA 91355).</p></sec><sec id="mgg3230-sec-0010"><title>Quality control and filtering</title><p>GenomeStudio data were imported to SVS 7.6.7, Golden Helix's<sup>&#x000ae;</sup> (Golden Helix, Inc. Bozeman, MT (<ext-link ext-link-type="uri" xlink:href="http://www.goldenhelix.com">http://www.goldenhelix.com</ext-link>), an integrated collection of analytic tools for managing, analyzing, and visualizing multifaceted genomic and phenotypic data. Parameters for&#x000a0;excluding markers from analyses included: (1) deviations from the Hardy&#x02013;Weinberg equilibrium with <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>0.0000002 (0.05/250.000 markers) in both cases and controls, (2) a genotype call rate &#x0003c;90%, and (3) the presence of both more or less than two alleles. Genotype and allelic frequencies were estimated by maximum likelihood. Data subsets for common and rare variants where established using a minor allele frequency (MAF) criterion of 1.0% that was estimated from the whole sample data. Linkage disequilibrium (LD) pruning using CHM was applied to the subset of common markers using as parameters a window size of 50 markers with a window increment of 50 and an <italic>r</italic>
<sup>2</sup> threshold of 0.5. With this pruned subset of common markers, matrices of identity by descent (IBD) and probability of identity were estimated. Those were used afterward for the mixed models analyses.</p></sec><sec id="mgg3230-sec-0011"><title>Genetic analysis</title><p>Single allelic, additive, and dominant linear&#x02010;mixed effect models (LMEMs) (Liu and Leal <xref rid="mgg3230-bib-0021" ref-type="ref">2010a</xref>,<xref rid="mgg3230-bib-0022" ref-type="ref">b</xref>; Segura et&#x000a0;al. <xref rid="mgg3230-bib-0029" ref-type="ref">2012</xref>) were fitted to test the association of these variants to ADHD. The advantage of these models is the inclusion of both fixed (sex and years of education, among other clinical variables) and random effects (the later to account for kinship effects by including the IBD matrix). The single&#x02010;locus LMEM assumes that all loci have a small effect on the trait, while multi&#x02010;locus LMEM assume that several loci have a large effect on the trait. In a single&#x02010;locus model, the association between the variant of interest and the disease trait is tested after covariates and genetic stratification are controlled for. Conversely, in a multi&#x02010;locus model the association is tested after covariates, genetic stratification and the effect of the remaining <italic>m</italic>&#x02010;1 variants are controlled for. These recently emerged methods have been proven to be more powerful than existing methods (Segura et&#x000a0;al. <xref rid="mgg3230-bib-0029" ref-type="ref">2012</xref>). Furthermore, this family of models allows handling of confounding effects and account for loci of small&#x02010; and large&#x02010;effect in structured populations with a small computational burden (Segura et&#x000a0;al. <xref rid="mgg3230-bib-0029" ref-type="ref">2012</xref>). Variants significantly associated with the ADHD phenotype were determined after correction by multiple testing using the false discovery rate (FDR) (Benjamini and Hochberg <xref rid="mgg3230-bib-0006" ref-type="ref">1995</xref>) and an alternative method based on extreme&#x02010;values theory (V&#x000e9;lez et&#x000a0;al. <xref rid="mgg3230-bib-0031" ref-type="ref">2014</xref>). As this is an attempt of evaluate an already known association, we have used the criterion of a <italic>P</italic>&#x02010;value &#x02264;0.10 to consider a positive replication.</p></sec></sec><sec id="mgg3230-sec-0012"><title>Results</title><p>A full description of demographic and clinical variables of the MTA has been published elsewhere (1999; Jensen et&#x000a0;al. <xref rid="mgg3230-bib-0018" ref-type="ref">2007</xref>; Molina et&#x000a0;al. <xref rid="mgg3230-bib-0026" ref-type="ref">2013</xref>, <xref rid="mgg3230-bib-0025" ref-type="ref">2009</xref>; Molina and Pelham <xref rid="mgg3230-bib-0024" ref-type="ref">2003</xref>). For a genetic add&#x02010;on we genotyped 371 volunteers (280 males, 75%), consisting of 232/579&#x000a0;=&#x000a0;40.0% of the MTA group and 139/289&#x000a0;=&#x000a0;48.1% of the LNCG. Diagnoses from the 6&#x02010;year DISC&#x02010;P were available for 205 of the MTA and 127 of the LNCG volunteers. For the 205 MTA participants in the genetic add&#x02010;on study, 30/205 (14.6%) retained the DISC&#x02010;P diagnosis of ADHD&#x02010;C in adolescence, but 175/205 (85.4%) did not, with switches in adolescence to ADHD&#x02010;Inattentive Type (ADHD&#x02010;I) for 59/205 (28.8%), ADHD&#x02010;Hyperactive Type (ADHD&#x02010;HI) for 8/205&#x000a0;=&#x000a0;3.9%, and no subtype of ADHD for 108/205 (52.7%). For the 127 LNCG participants in the genetic add&#x02010;on study, 112/127 (88.2%) remained undiagnosed in adolescence by the DISC&#x02010;P, but 15/127 (11.8%) did not, and all of these 15 were diagnosed with Adolescent ADHD&#x02010;I (see Fig.&#x000a0;<xref rid="mgg3230-fig-0001" ref-type="fig">1</xref> and Table&#x000a0;<xref rid="mgg3230-tbl-0001" ref-type="table-wrap">1</xref>).</p><fig fig-type="Figure" xml:lang="en" id="mgg3230-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Diagram&#x000a0;of individuals participation in the studies and collected <styled-content style="fixed-case">DNA</styled-content> samples in relation of <styled-content style="fixed-case">ADHD</styled-content> diagnosis.</p></caption><graphic id="nlm-graphic-3" xlink:href="MGG3-4-540-g001"/></fig><table-wrap id="mgg3230-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Cross tabulation of ADHD combined type based on the diagnostic interview schedule for children&#x02013;parent version (DISC&#x02010;P) administered at the 6&#x02010;year follow&#x02010;up assessment (PAD3Y) versus the diagnosis of ADHD at the baseline. The unknown category refers to those cases without PAD3Y criteria. The 112 LNCG are those that did not match ADHD criteria at the 6&#x02010;year follow&#x02010;up assessment, that is, 15 individuals</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr><th align="left" valign="top" rowspan="1" colspan="1">SJTYP</th><th align="left" valign="top" rowspan="1" colspan="1">PAD3Y</th><th align="left" valign="top" rowspan="1" colspan="1">PAD3Y</th><th align="left" valign="top" rowspan="1" colspan="1">PAD3Y</th><th align="left" valign="top" rowspan="1" colspan="1">Row</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">Control</th><th align="left" valign="top" rowspan="1" colspan="1">ADHD combined type</th><th align="left" valign="top" rowspan="1" colspan="1">Unknown</th><th align="left" valign="top" rowspan="1" colspan="1">Totals</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">MTA</td><td align="left" rowspan="1" colspan="1">175</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">232</td></tr><tr><td align="left" rowspan="1" colspan="1">LNCG</td><td align="left" rowspan="1" colspan="1">112</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">124</td></tr><tr><td align="left" rowspan="1" colspan="1">Totals</td><td align="left" rowspan="1" colspan="1">287</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">356</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>Using LMEMs we initially compared allelic, genotype, and haplotype data of MTA and LNCG at the base line diagnosis but found no significant differences. For the subgroup with persisting combined type ADHD, we found significant associations with <italic>ADGRL3</italic> for allelic and haplotype comparisons, when compared with the other adolescent subgroups (adolescent ADHD&#x02010;I, ADHD&#x02010;HI, or Non&#x02010;ADHD). The minor allele C at the marker rs2345039 was significant (<italic>P</italic>&#x000a0;=&#x000a0;0.005) after corrections by multiple comparisons (<italic>P</italic>
<sub>FDR&#x000a0;</sub>=&#x000a0;0.04), which is the same marker reported to be significant in the original manuscript that described variants harbored in <italic>ADGRL3</italic>conferring susceptibility to ADHD by our group (Arcos&#x02010;Burgos et&#x000a0;al. <xref rid="mgg3230-bib-0004" ref-type="ref">2010</xref>). The haplotype analysis show that a haplotype involving rs2345039&#x02010;rs61747658&#x02010;rs1397548 (CAA) is significantly associated with a refined phenotype of adolescent&#x02010;persistent ADHD&#x02010;C when compared with the LNCG (<italic>P</italic>&#x000a0;=&#x000a0;0.005, <italic>P</italic>
<sub>FDR&#x000a0;</sub>=&#x000a0;0.05; Odds ratio&#x000a0;=&#x000a0;3.47, CI&#x02010;95% 1.37&#x02013;8.74 (Table&#x000a0;<xref rid="mgg3230-tbl-0002" ref-type="table-wrap">2</xref>). This significant association, based on a comparison of the <italic>n</italic>&#x000a0;=&#x000a0;30 cases with persistent ADHD&#x02010;C versus the LNCG, was independent of the fitted model, that is, allelic, genotype dominant, or genotype codominant, and in each case the association tolerated FDR correction (Table&#x000a0;<xref rid="mgg3230-tbl-0003" ref-type="table-wrap">3</xref>). We also compared the subgroup with persisting ADHD&#x02010;C with the subgroup consisting of the other subtypes representing partial manifestation of the full syndrome (ADHD&#x02010;I and ADHD&#x02010;HI), but we found no differences.</p><table-wrap id="mgg3230-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Allelic association analysis of markers harbored in the <italic>ADGRL3</italic> (Accession number NC_000004.12, GRCh38.p2). An FDR correction was applied to account for multiple comparisons</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">Chr</th><th align="left" valign="top" rowspan="1" colspan="1">Position</th><th align="left" valign="top" rowspan="1" colspan="1">Func</th><th align="left" valign="top" rowspan="1" colspan="1">HGVS nomenclature</th><th align="left" valign="top" rowspan="1" colspan="1">Corr/Trend <italic>P</italic>
</th><th align="left" valign="top" rowspan="1" colspan="1">Corr/Trend FDR</th><th align="left" valign="top" rowspan="1" colspan="1">Odds ratio (minor allele)</th><th align="left" valign="top" rowspan="1" colspan="1">OR lower confidence bound (minor)</th><th align="left" valign="top" rowspan="1" colspan="1">OR upper confidence bound (minor)</th><th align="left" valign="top" rowspan="1" colspan="1">Minor allele (test allele)</th><th align="left" valign="top" rowspan="1" colspan="1">Minor allele frequency</th><th align="left" valign="top" rowspan="1" colspan="1">Allele freq. (cases)</th><th align="left" valign="top" rowspan="1" colspan="1">Allele freq. (controls)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">rs2345039</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62765029</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">g.61899312G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">0.005</td><td align="left" rowspan="1" colspan="1">0.044</td><td align="left" rowspan="1" colspan="1">2.225</td><td align="left" rowspan="1" colspan="1">1.262</td><td align="left" rowspan="1" colspan="1">3.922</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">0.437</td><td align="left" rowspan="1" colspan="1">0.625</td><td align="left" rowspan="1" colspan="1">0.428</td></tr><tr><td align="left" rowspan="1" colspan="1">rs11131347</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62759269</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">g.61893552C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">0.040</td><td align="left" rowspan="1" colspan="1">0.181</td><td align="left" rowspan="1" colspan="1">1.761</td><td align="left" rowspan="1" colspan="1">1.021</td><td align="left" rowspan="1" colspan="1">3.039</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.485</td><td align="left" rowspan="1" colspan="1">0.617</td><td align="left" rowspan="1" colspan="1">0.477</td></tr><tr><td align="left" rowspan="1" colspan="1">rs6856328</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62437317</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">g.61571600C&#x0003e;G</td><td align="left" rowspan="1" colspan="1">0.122</td><td align="left" rowspan="1" colspan="1">0.367</td><td align="left" rowspan="1" colspan="1">2.694</td><td align="left" rowspan="1" colspan="1">0.730</td><td align="left" rowspan="1" colspan="1">9.937</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">0.027</td><td align="left" rowspan="1" colspan="1">0.050</td><td align="left" rowspan="1" colspan="1">0.019</td></tr><tr><td align="left" rowspan="1" colspan="1">rs61747658</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62800623</td><td align="left" rowspan="1" colspan="1">missense</td><td align="left" rowspan="1" colspan="1">g.61934906A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">0.390</td><td align="left" rowspan="1" colspan="1">0.878</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.011</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1">0.012</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2172802</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62453208</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">g.61587491A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">0.437</td><td align="left" rowspan="1" colspan="1">0.787</td><td align="left" rowspan="1" colspan="1">1.248</td><td align="left" rowspan="1" colspan="1">0.713</td><td align="left" rowspan="1" colspan="1">2.184</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.295</td><td align="left" rowspan="1" colspan="1">0.350</td><td align="left" rowspan="1" colspan="1">0.301</td></tr><tr><td align="left" rowspan="1" colspan="1">rs35106420</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62758490</td><td align="left" rowspan="1" colspan="1">missense</td><td align="left" rowspan="1" colspan="1">g.61892773G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">0.468</td><td align="left" rowspan="1" colspan="1">0.702</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.011</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">rs6551665</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62739540</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">g.61873823G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">0.542</td><td align="left" rowspan="1" colspan="1">0.696</td><td align="left" rowspan="1" colspan="1">1.188</td><td align="left" rowspan="1" colspan="1">0.683</td><td align="left" rowspan="1" colspan="1">2.066</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.404</td><td align="left" rowspan="1" colspan="1">0.446</td><td align="left" rowspan="1" colspan="1">0.404</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1947274</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62744239</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">g.61878522C&#x0003e;A</td><td align="left" rowspan="1" colspan="1">0.596</td><td align="left" rowspan="1" colspan="1">0.670</td><td align="left" rowspan="1" colspan="1">1.162</td><td align="left" rowspan="1" colspan="1">0.668</td><td align="left" rowspan="1" colspan="1">2.020</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">0.411</td><td align="left" rowspan="1" colspan="1">0.446</td><td align="left" rowspan="1" colspan="1">0.410</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1397548</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62845489</td><td align="left" rowspan="1" colspan="1">coding&#x02010;synon</td><td align="left" rowspan="1" colspan="1">g.61979772A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">0.908</td><td align="left" rowspan="1" colspan="1">0.908</td><td align="left" rowspan="1" colspan="1">0.967</td><td align="left" rowspan="1" colspan="1">0.546</td><td align="left" rowspan="1" colspan="1">1.712</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.324</td><td align="left" rowspan="1" colspan="1">0.317</td><td align="left" rowspan="1" colspan="1">0.324</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="mgg3230-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>Haplotype association analysis of markers harbored in the <italic>ADGRL3</italic> (Accession number NC_000004.12, GRCh38.p2). An FDR correction was applied</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">First marker</th><th align="left" valign="top" rowspan="1" colspan="1">Chr</th><th align="left" valign="top" rowspan="1" colspan="1">Position</th><th align="left" valign="top" rowspan="1" colspan="1">Ref allele NCBI</th><th align="left" valign="top" rowspan="1" colspan="1">Obs</th><th align="left" valign="top" rowspan="1" colspan="1">Func</th><th align="left" valign="top" rowspan="1" colspan="1">Block #</th><th align="left" valign="top" rowspan="1" colspan="1">Haplotype</th><th align="left" valign="top" rowspan="1" colspan="1">EM cases freq</th><th align="left" valign="top" rowspan="1" colspan="1">EM controls freq</th><th align="left" valign="top" rowspan="1" colspan="1">Chi&#x02010;squared <italic>P</italic>
</th><th align="left" valign="top" rowspan="1" colspan="1">Chi&#x02010;squared FDR</th><th align="left" valign="top" rowspan="1" colspan="1">Odds ratio</th><th align="left" valign="top" rowspan="1" colspan="1">Odds ratio lower 95% CI</th><th align="left" valign="top" rowspan="1" colspan="1">Odds ratio upper 95% CI</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">rs2345039</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62765029</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">C/G</td><td align="left" rowspan="1" colspan="1">introit</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">CAA</td><td align="left" rowspan="1" colspan="1">0.12</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.06</td><td align="left" rowspan="1" colspan="1">3.47</td><td align="left" rowspan="1" colspan="1">1.37</td><td align="left" rowspan="1" colspan="1">8.78</td></tr><tr><td align="left" rowspan="1" colspan="1">rs35106420</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62758490</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">GAC</td><td align="left" rowspan="1" colspan="1">0.62</td><td align="left" rowspan="1" colspan="1">0.42</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.08</td><td align="left" rowspan="1" colspan="1">2.22</td><td align="left" rowspan="1" colspan="1">1.26</td><td align="left" rowspan="1" colspan="1">3.91</td></tr><tr><td align="left" rowspan="1" colspan="1">rs11131347</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62759269</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">C/T</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">ACA</td><td align="left" rowspan="1" colspan="1">0.62</td><td align="left" rowspan="1" colspan="1">0.42</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">0.14</td><td align="left" rowspan="1" colspan="1">2.24</td><td align="left" rowspan="1" colspan="1">1.27</td><td align="left" rowspan="1" colspan="1">3.96</td></tr><tr><td align="left" rowspan="1" colspan="1">rs11131347</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62759269</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">C/T</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">GGA</td><td align="left" rowspan="1" colspan="1">0.37</td><td align="left" rowspan="1" colspan="1">0.51</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.20</td><td align="left" rowspan="1" colspan="1">0.56</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">0.99</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1947274</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62744239</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">A/C</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">AGA</td><td align="left" rowspan="1" colspan="1">0.26</td><td align="left" rowspan="1" colspan="1">0.15</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.20</td><td align="left" rowspan="1" colspan="1">2.00</td><td align="left" rowspan="1" colspan="1">1.05</td><td align="left" rowspan="1" colspan="1">3.82</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1947274</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62744239</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">A/C</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">AGG</td><td align="left" rowspan="1" colspan="1">0.30</td><td align="left" rowspan="1" colspan="1">0.44</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.21</td><td align="left" rowspan="1" colspan="1">0.54</td><td align="left" rowspan="1" colspan="1">0.30</td><td align="left" rowspan="1" colspan="1">0.98</td></tr><tr><td align="left" rowspan="1" colspan="1">rs35106420</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62758490</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">Missense</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">GGG</td><td align="left" rowspan="1" colspan="1">0.37</td><td align="left" rowspan="1" colspan="1">0.52</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">0.54</td><td align="left" rowspan="1" colspan="1">0.31</td><td align="left" rowspan="1" colspan="1">0.95</td></tr><tr><td align="left" rowspan="1" colspan="1">rs11131347</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62759269</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">C/T</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">AGA</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.11</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">rs2345039</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62765029</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">C/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">CAG</td><td align="left" rowspan="1" colspan="1">0.51</td><td align="left" rowspan="1" colspan="1">0.39</td><td align="left" rowspan="1" colspan="1">0.09</td><td align="left" rowspan="1" colspan="1">0.33</td><td align="left" rowspan="1" colspan="1">1.60</td><td align="left" rowspan="1" colspan="1">0.92</td><td align="left" rowspan="1" colspan="1">2.78</td></tr><tr><td align="left" rowspan="1" colspan="1">rs35106420</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62758490</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">missense</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">GAG</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.11</td><td align="left" rowspan="1" colspan="1">0.34</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">rs2345039</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62765029</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">C/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">GAG</td><td align="left" rowspan="1" colspan="1">0.17</td><td align="left" rowspan="1" colspan="1">0.28</td><td align="left" rowspan="1" colspan="1">0.09</td><td align="left" rowspan="1" colspan="1">0.36</td><td align="left" rowspan="1" colspan="1">0.54</td><td align="left" rowspan="1" colspan="1">0.26</td><td align="left" rowspan="1" colspan="1">1.11</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2345039</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62765029</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">C/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">GAA</td><td align="left" rowspan="1" colspan="1">0.20</td><td align="left" rowspan="1" colspan="1">0.28</td><td align="left" rowspan="1" colspan="1">0.21</td><td align="left" rowspan="1" colspan="1">0.55</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">0.33</td><td align="left" rowspan="1" colspan="1">1.28</td></tr><tr><td align="left" rowspan="1" colspan="1">rs6856328</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62437317</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">C/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">GGG</td><td align="left" rowspan="1" colspan="1">0.19</td><td align="left" rowspan="1" colspan="1">0.14</td><td align="left" rowspan="1" colspan="1">0.26</td><td align="left" rowspan="1" colspan="1">0.59</td><td align="left" rowspan="1" colspan="1">1.50</td><td align="left" rowspan="1" colspan="1">0.74</td><td align="left" rowspan="1" colspan="1">3.04</td></tr><tr><td align="left" rowspan="1" colspan="1">rs6856328</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62437317</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">C/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">CAG</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.02</td><td align="left" rowspan="1" colspan="1">0.29</td><td align="left" rowspan="1" colspan="1">0.62</td><td align="left" rowspan="1" colspan="1">2.27</td><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="1" colspan="1">10.84</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2345039</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62765029</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">C/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">GGG</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.39</td><td align="left" rowspan="1" colspan="1">0.63</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">rs2172802</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62453208</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">GGC</td><td align="left" rowspan="1" colspan="1">0.19</td><td align="left" rowspan="1" colspan="1">0.14</td><td align="left" rowspan="1" colspan="1">0.26</td><td align="left" rowspan="1" colspan="1">0.63</td><td align="left" rowspan="1" colspan="1">1.50</td><td align="left" rowspan="1" colspan="1">0.74</td><td align="left" rowspan="1" colspan="1">3.05</td></tr><tr><td align="left" rowspan="1" colspan="1">rs11131347</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62759269</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">C/T</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">GGG</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.39</td><td align="left" rowspan="1" colspan="1">0.66</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">rs61747658</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62800623</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">missense</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.39</td><td align="left" rowspan="1" colspan="1">0.69</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">rs6856328</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62437317</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">C/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">GAA</td><td align="left" rowspan="1" colspan="1">0.37</td><td align="left" rowspan="1" colspan="1">0.44</td><td align="left" rowspan="1" colspan="1">0.35</td><td align="left" rowspan="1" colspan="1">0.71</td><td align="left" rowspan="1" colspan="1">0.77</td><td align="left" rowspan="1" colspan="1">0.43</td><td align="left" rowspan="1" colspan="1">1.35</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2172802</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62453208</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">AAA</td><td align="left" rowspan="1" colspan="1">0.37</td><td align="left" rowspan="1" colspan="1">0.43</td><td align="left" rowspan="1" colspan="1">0.39</td><td align="left" rowspan="1" colspan="1">0.73</td><td align="left" rowspan="1" colspan="1">0.78</td><td align="left" rowspan="1" colspan="1">0.44</td><td align="left" rowspan="1" colspan="1">1.37</td></tr><tr><td align="left" rowspan="1" colspan="1">rs6551665</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62739540</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">AAG</td><td align="left" rowspan="1" colspan="1">0.55</td><td align="left" rowspan="1" colspan="1">0.58</td><td align="left" rowspan="1" colspan="1">0.60</td><td align="left" rowspan="1" colspan="1">0.80</td><td align="left" rowspan="1" colspan="1">0.86</td><td align="left" rowspan="1" colspan="1">0.50</td><td align="left" rowspan="1" colspan="1">1.50</td></tr><tr><td align="left" rowspan="1" colspan="1">rs6551665</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62739540</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">GCG</td><td align="left" rowspan="1" colspan="1">0.45</td><td align="left" rowspan="1" colspan="1">0.40</td><td align="left" rowspan="1" colspan="1">0.60</td><td align="left" rowspan="1" colspan="1">0.80</td><td align="left" rowspan="1" colspan="1">1.16</td><td align="left" rowspan="1" colspan="1">0.67</td><td align="left" rowspan="1" colspan="1">2.02</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1947274</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62744239</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">A/C</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">CGA</td><td align="left" rowspan="1" colspan="1">0.37</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">0.53</td><td align="left" rowspan="1" colspan="1">0.80</td><td align="left" rowspan="1" colspan="1">1.20</td><td align="left" rowspan="1" colspan="1">0.68</td><td align="left" rowspan="1" colspan="1">2.13</td></tr><tr><td align="left" rowspan="1" colspan="1">rs6856328</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62437317</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">C/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">GGA</td><td align="left" rowspan="1" colspan="1">0.18</td><td align="left" rowspan="1" colspan="1">0.16</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">0.84</td><td align="left" rowspan="1" colspan="1">1.18</td><td align="left" rowspan="1" colspan="1">0.58</td><td align="left" rowspan="1" colspan="1">2.41</td></tr><tr><td align="left" rowspan="1" colspan="1">rs6856328</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62437317</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">C/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">GAG</td><td align="left" rowspan="1" colspan="1">0.22</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">0.58</td><td align="left" rowspan="1" colspan="1">0.84</td><td align="left" rowspan="1" colspan="1">0.83</td><td align="left" rowspan="1" colspan="1">0.43</td><td align="left" rowspan="1" colspan="1">1.61</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2172802</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62453208</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">GAA</td><td align="left" rowspan="1" colspan="1">0.18</td><td align="left" rowspan="1" colspan="1">0.16</td><td align="left" rowspan="1" colspan="1">0.70</td><td align="left" rowspan="1" colspan="1">0.86</td><td align="left" rowspan="1" colspan="1">1.15</td><td align="left" rowspan="1" colspan="1">0.56</td><td align="left" rowspan="1" colspan="1">2.35</td></tr><tr><td align="left" rowspan="1" colspan="1">rs61747658</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62800623</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">missense</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">0.68</td><td align="left" rowspan="1" colspan="1">0.66</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">0.90</td><td align="left" rowspan="1" colspan="1">1.09</td><td align="left" rowspan="1" colspan="1">0.62</td><td align="left" rowspan="1" colspan="1">1.93</td></tr><tr><td align="left" rowspan="1" colspan="1">rs61747658</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62800623</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">missense</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.55</td><td align="left" rowspan="1" colspan="1">1.71</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1947274</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62744239</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">A/C</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">CGG</td><td align="left" rowspan="1" colspan="1">0.08</td><td align="left" rowspan="1" colspan="1">0.09</td><td align="left" rowspan="1" colspan="1">0.83</td><td align="left" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="1" colspan="1">0.89</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">2.48</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2172802</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62453208</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">intron</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">AGC</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">0.27</td><td align="left" rowspan="1" colspan="1">0.80</td><td align="left" rowspan="1" colspan="1">0.92</td><td align="left" rowspan="1" colspan="1">0.92</td><td align="left" rowspan="1" colspan="1">0.49</td><td align="left" rowspan="1" colspan="1">1.73</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1397548</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62845489</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">coding&#x02010;synon</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.68</td><td align="left" rowspan="1" colspan="1">0.68</td><td align="left" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="1" colspan="1">0.94</td><td align="left" rowspan="1" colspan="1">1.03</td><td align="left" rowspan="1" colspan="1">0.58</td><td align="left" rowspan="1" colspan="1">1.83</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1397548</td><td align="left" rowspan="1" colspan="1">chr4</td><td align="left" rowspan="1" colspan="1">62845489</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">A/G</td><td align="left" rowspan="1" colspan="1">coding&#x02010;synon</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.55</td><td align="left" rowspan="1" colspan="1">1.71</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="mgg3230-sec-0013"><title>Discussion</title><p>A large number of studies show that <italic>ADGRL3</italic> variants predispose to ADHD, modulate the pattern of brain metabolism, and predict ADHD severity (comorbidity with conduct disorder [CD], oppositional defiant disorder [ODD], and substance used disorder [SUD]) and response to stimulant medication (Arcos&#x02010;Burgos and Muenke <xref rid="mgg3230-bib-0002" ref-type="ref">2010</xref>; Arcos&#x02010;Burgos et&#x000a0;al. <xref rid="mgg3230-bib-0004" ref-type="ref">2010</xref>, <xref rid="mgg3230-bib-0005" ref-type="ref">2012</xref>; Acosta et&#x000a0;al. <xref rid="mgg3230-bib-0001" ref-type="ref">2011</xref>; Martinez et&#x000a0;al. <xref rid="mgg3230-bib-0023" ref-type="ref">2011</xref>; Ribases et&#x000a0;al. <xref rid="mgg3230-bib-0028" ref-type="ref">2011</xref>; Jain et&#x000a0;al. <xref rid="mgg3230-bib-0017" ref-type="ref">2012</xref>). Furthermore, <italic>ADGRL3</italic> susceptibility variants interact with haplotype variants harbored at chromosome 11q22 in the region of <italic>NCAM1, TTC12, ANKK1,</italic> and <italic>DRD2</italic> genes (Jain et&#x000a0;al. <xref rid="mgg3230-bib-0017" ref-type="ref">2012</xref>). It is clear now that the association between ADHD and <italic>ADGRL3</italic> variants identifies a subtype of the condition characterized by the presence of severe externalizing symptoms and consequently a complex prognosis of persistence and graveness.</p><p>In this manuscript, we present additional evidence that the <italic>ADGRL3</italic> variant rs2345039, previously reported to be associated with the ADHD susceptibility haplotype, predisposes to the development of a refined ADHD phenotype characterized by persistence of ADHD combined subtype symptoms into adolescence. The fact that we are detecting association of the <italic>ADGRL3</italic> variants in an extreme phenotype based on outcome of 6 years after childhood diagnosis &#x02013; and confirmed by a rigorous prospective follow&#x02010;up &#x02013; provides additional evidence that the association with <italic>ADGRL3</italic> not only is not spurious, but also is associated with a more severe form of ADHD.</p><p>These findings may partially explain the heterogeneity of longitudinal course in ADHD that includes differential symptom reduction with age, comorbidity, and ultimately, overall long&#x02010;term physical and mental health. Limitations of this study include the use of a final small sample size for those with persistent phenotype for ADHD at 6&#x000a0;years of age. However, it is known that in small sample size cohorts, where a high number of markers have been genotyped, major fluctuations in the distribution of significant values might appear and, consequently, spurious associations might reach significance. To control for this problem, we corrected by multiple comparisons using FDR as described in the Methods section. Furthermore, given that the direction of association between ADHD susceptibility and LPHN3 variants is well known, a <italic>P</italic>&#x02010;value of 0.10 was selected as the threshold to declare significance. The reason for selecting this threshold lies in the demonstration that for a given <italic>P</italic>&#x02010;value, the probability of replicating a significant result, under certain assumptions, is smaller than expected. Or better, as described by Goodman (Goodman <xref rid="mgg3230-bib-0013" ref-type="ref">1992</xref>): &#x0201c;It is shown that if the observed difference is the true one, the probability of repeating a statistically significant result, the &#x0201c;replication probability&#x0201d;, is substantially lower than expected&#x0201d;.</p><p>Continued research on this genetic variant in samples followed into adulthood, and that include comprehensive assessment of symptoms and functioning, is warranted.</p></sec><sec id="mgg3230-sec-0014"><title>Conflict of Interest</title><p>The authors declare no conflict of interests.</p></sec></body><back><ref-list content-type="cited-references" id="mgg3230-bibl-0001"><title>References</title><ref id="mgg3230-bib-0001"><mixed-citation publication-type="journal" id="mgg3230-cit-0001">
<string-name>
<surname>Acosta</surname>, <given-names>M. T.</given-names>
</string-name>, <string-name>
<given-names>J. I.</given-names>
<surname>Velez</surname>
</string-name>, <string-name>
<given-names>M. L.</given-names>
<surname>Bustamante</surname>
</string-name>, <string-name>
<given-names>J. Z.</given-names>
<surname>Balog</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Arcos&#x02010;Burgos</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Muenke</surname>
</string-name>. <year>2011</year>
<article-title>A two&#x02010;locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long&#x02010;term outcome</article-title>. <source>Transl. Psychiatry</source>
<volume>1</volume>:<fpage>e17</fpage>.<pub-id pub-id-type="pmid">22832519</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0002"><mixed-citation publication-type="journal" id="mgg3230-cit-0002">
<string-name>
<surname>Arcos&#x02010;Burgos</surname>, <given-names>M.</given-names>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Muenke</surname>
</string-name>. <year>2010</year>
<article-title>Toward a better understanding of ADHD: LPHN3 gene variants and the susceptibility to develop ADHD</article-title>. <source>Atten. Defic. Hyperact. Disord.</source>
<volume>2</volume>:<fpage>139</fpage>&#x02013;<lpage>147</lpage>.<pub-id pub-id-type="pmid">21432600</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0003"><mixed-citation publication-type="journal" id="mgg3230-cit-0003">
<string-name>
<surname>Arcos&#x02010;Burgos</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>F. X.</given-names>
<surname>Castellanos</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Pineda</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Lopera</surname>
</string-name>, <string-name>
<given-names>J. D.</given-names>
<surname>Palacio</surname>
</string-name>, <string-name>
<given-names>L. G.</given-names>
<surname>Palacio</surname>
</string-name>, et&#x000a0;al. <year>2004</year>
<article-title>Attention&#x02010;deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11</article-title>. <source>Am. J. Hum. Genet.</source>
<volume>75</volume>:<fpage>998</fpage>&#x02013;<lpage>1014</lpage>.<pub-id pub-id-type="pmid">15497111</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0004"><mixed-citation publication-type="journal" id="mgg3230-cit-0004">
<string-name>
<surname>Arcos&#x02010;Burgos</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Jain</surname>
</string-name>, <string-name>
<given-names>M. T.</given-names>
<surname>Acosta</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Shively</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Stanescu</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Wallis</surname>
</string-name>, et&#x000a0;al. <year>2010</year>
<article-title>A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication</article-title>. <source>Mol. Psychiatry</source>
<volume>15</volume>:<fpage>1053</fpage>&#x02013;<lpage>1066</lpage>.<pub-id pub-id-type="pmid">20157310</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0005"><mixed-citation publication-type="journal" id="mgg3230-cit-0005">
<string-name>
<surname>Arcos&#x02010;Burgos</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>J. I.</given-names>
<surname>Velez</surname>
</string-name>, <string-name>
<given-names>B. D.</given-names>
<surname>Solomon</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Muenke</surname>
</string-name>. <year>2012</year>
<article-title>A common genetic network underlies substance use disorders and disruptive or externalizing disorders</article-title>. <source>Hum. Genet.</source>
<volume>131</volume>:<fpage>917</fpage>&#x02013;<lpage>929</lpage>.<pub-id pub-id-type="pmid">22492058</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0006"><mixed-citation publication-type="journal" id="mgg3230-cit-0006">
<string-name>
<surname>Benjamini</surname>, <given-names>Y.</given-names>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Hochberg</surname>
</string-name>. <year>1995</year>
<article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>. <source>J. R. Stat. Soc. Series B Stat. Methodol.</source>
<volume>57</volume>:<fpage>289</fpage>&#x02013;<lpage>300</lpage>.</mixed-citation></ref><ref id="mgg3230-bib-0007"><mixed-citation publication-type="journal" id="mgg3230-cit-0007">
<string-name>
<surname>Bruxel</surname>, <given-names>E. M.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Salatino&#x02010;Oliveira</surname>
</string-name>, <string-name>
<given-names>G. C.</given-names>
<surname>Akutagava&#x02010;Martins</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Tovo&#x02010;Rodrigues</surname>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Genro</surname>
</string-name>, <string-name>
<given-names>C. P.</given-names>
<surname>Zeni</surname>
</string-name>, et&#x000a0;al. <year>2015</year>
<article-title>LPHN3 and attention&#x02010;deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study</article-title>. <source>Genes Brain Behav.</source>
<volume>14</volume>:<fpage>419</fpage>&#x02013;<lpage>427</lpage>.<pub-id pub-id-type="pmid">25989180</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0008"><mixed-citation publication-type="journal" id="mgg3230-cit-0008">
<string-name>
<surname>Choudhry</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Sengupta</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Grizenko</surname>
</string-name>, <string-name>
<given-names>M. E.</given-names>
<surname>Fortier</surname>
</string-name>, <string-name>
<given-names>G. A.</given-names>
<surname>Thakur</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Bellingham</surname>
</string-name>, et&#x000a0;al. <year>2012</year>
<article-title>LPHN3 and attention&#x02010;deficit/hyperactivity disorder: interaction with maternal stress during pregnancy</article-title>. <source>J. Child Psychol. Psychiatry</source>
<volume>53</volume>:<fpage>892</fpage>&#x02013;<lpage>902</lpage>.<pub-id pub-id-type="pmid">22486528</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0009"><mixed-citation publication-type="journal" id="mgg3230-cit-0009">
<string-name>
<surname>Domene</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Stanescu</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Wallis</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Tinloy</surname>
</string-name>, <string-name>
<given-names>D. E.</given-names>
<surname>Pineda</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Kleta</surname>
</string-name>, et&#x000a0;al. <year>2011</year>
<article-title>Screening of human LPHN3 for variants with a potential impact on ADHD susceptibility</article-title>. <source>Am. J. Med. Genet. B Neuropsychiatr. Genet.</source>
<volume>156B</volume>:<fpage>11</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">21184580</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0010"><mixed-citation publication-type="journal" id="mgg3230-cit-0010">
<string-name>
<surname>Fallgatter</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<given-names>A. C.</given-names>
<surname>Ehlis</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Dresler</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Reif</surname>
</string-name>, <string-name>
<given-names>C. P.</given-names>
<surname>Jacob</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Arcos&#x02010;Burgos</surname>
</string-name>, et&#x000a0;al. <year>2013</year>
<article-title>Influence of a Latrophilin 3 (LPHN3) risk haplotype on event&#x02010;related potential measures of cognitive response control in attention&#x02010;deficit hyperactivity disorder (ADHD)</article-title>. <source>Eur. Neuropsychopharmacol.</source>
<volume>23</volume>:<fpage>458</fpage>&#x02013;<lpage>468</lpage>.<pub-id pub-id-type="pmid">23245769</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0011"><mixed-citation publication-type="journal" id="mgg3230-cit-0011">
<string-name>
<surname>Faraone</surname>, <given-names>S. V.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Biederman</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Spencer</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Mick</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Murray</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Petty</surname>
</string-name>, et&#x000a0;al. <year>2006</year>
<article-title>Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?</article-title>
<source>Am. J. Psychiatry</source>, <volume>163</volume>:<fpage>1720</fpage>&#x02013;<lpage>1729</lpage>; quiz 1859.<pub-id pub-id-type="pmid">17012682</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0012"><mixed-citation publication-type="journal" id="mgg3230-cit-0012">
<string-name>
<surname>Franke</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<given-names>S. V.</given-names>
<surname>Faraone</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Asherson</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Buitelaar</surname>
</string-name>, <string-name>
<given-names>C. H.</given-names>
<surname>Bau</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Ramos&#x02010;Quiroga</surname>
</string-name>, et&#x000a0;al. <year>2012</year>
<article-title>The genetics of attention deficit/hyperactivity disorder in adults, a review</article-title>. <source>Mol. Psychiatry</source>
<volume>17</volume>:<fpage>960</fpage>&#x02013;<lpage>987</lpage>.<pub-id pub-id-type="pmid">22105624</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0013"><mixed-citation publication-type="journal" id="mgg3230-cit-0013">
<string-name>
<surname>Goodman</surname>, <given-names>S. N.</given-names>
</string-name>
<year>1992</year>
<article-title>A comment on replication, p&#x02010;values and evidence</article-title>. <source>Stat. Med.</source>
<volume>11</volume>:<fpage>875</fpage>&#x02013;<lpage>879</lpage>.<pub-id pub-id-type="pmid">1604067</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0015"><mixed-citation publication-type="journal" id="mgg3230-cit-0015">
<string-name>
<surname>Hwang</surname>, <given-names>I. W.</given-names>
</string-name>, <string-name>
<given-names>M. H.</given-names>
<surname>Lim</surname>
</string-name>, <string-name>
<given-names>H. J.</given-names>
<surname>Kwon</surname>
</string-name>, and <string-name>
<given-names>H. J.</given-names>
<surname>Jin</surname>
</string-name>. <year>2015</year>
<article-title>Association of LPHN3 rs6551665 A/G polymorphism with attention deficit and hyperactivity disorder in Korean children</article-title>. <source>Gene</source>
<volume>566</volume>:<fpage>68</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">25871512</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0016"><mixed-citation publication-type="journal" id="mgg3230-cit-0016">
<string-name>
<surname>Jain</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>L. G.</given-names>
<surname>Palacio</surname>
</string-name>, <string-name>
<given-names>F. X.</given-names>
<surname>Castellanos</surname>
</string-name>, <string-name>
<given-names>J. D.</given-names>
<surname>Palacio</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Pineda</surname>
</string-name>, <string-name>
<given-names>M. I.</given-names>
<surname>Restrepo</surname>
</string-name>, et&#x000a0;al. <year>2007</year>
<article-title>Attention&#x02010;deficit/hyperactivity disorder and comorbid disruptive behavior disorders: evidence of pleiotropy and new susceptibility loci</article-title>. <source>Biol. Psychiatry</source>
<volume>61</volume>:<fpage>1329</fpage>&#x02013;<lpage>1339</lpage>.<pub-id pub-id-type="pmid">16950213</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0017"><mixed-citation publication-type="journal" id="mgg3230-cit-0017">
<string-name>
<surname>Jain</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>J. I.</given-names>
<surname>Velez</surname>
</string-name>, <string-name>
<given-names>M. T.</given-names>
<surname>Acosta</surname>
</string-name>, <string-name>
<given-names>L. G.</given-names>
<surname>Palacio</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Balog</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Roessler</surname>
</string-name>, et&#x000a0;al. <year>2012</year>
<article-title>A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD</article-title>. <source>Mol. Psychiatry</source>
<volume>17</volume>:<fpage>741</fpage>&#x02013;<lpage>747</lpage>.<pub-id pub-id-type="pmid">21606926</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0018"><mixed-citation publication-type="journal" id="mgg3230-cit-0018">
<string-name>
<surname>Jensen</surname>, <given-names>P. S.</given-names>
</string-name>, <string-name>
<given-names>L. E.</given-names>
<surname>Arnold</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Swanson</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Vitiello</surname>
</string-name>, <string-name>
<given-names>H. B.</given-names>
<surname>Abikoff</surname>
</string-name>, <string-name>
<given-names>L. L.</given-names>
<surname>Greenhill</surname>
</string-name>, et&#x000a0;al. <year>2007</year>
<article-title>3&#x02010;year follow&#x02010;up of the NIMH MTA study</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>46</volume>:<fpage>989</fpage>&#x02013;<lpage>1002</lpage>.<pub-id pub-id-type="pmid">17667478</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0019"><mixed-citation publication-type="journal" id="mgg3230-cit-0019">
<string-name>
<surname>Labbe</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Atherton</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Gizenko</surname>
</string-name>, <string-name>
<given-names>M. E.</given-names>
<surname>Fortier</surname>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Sengupta</surname>
</string-name>, et&#x000a0;al. <year>2012</year>
<article-title>Refining psychiatric phenotypes for response to treatment: contribution of LPHN3 in ADHD</article-title>. <source>Am. J. Med. Genet. B Neuropsychiatr. Genet.</source>
<volume>159B</volume>:<fpage>776</fpage>&#x02013;<lpage>785</lpage>.<pub-id pub-id-type="pmid">22851411</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0020"><mixed-citation publication-type="journal" id="mgg3230-cit-0020">
<string-name>
<surname>Lange</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Norton</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Coolen</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Chaminade</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Merker</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Proft</surname>
</string-name>, et&#x000a0;al. <year>2012</year>
<article-title>The ADHD&#x02010;susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development</article-title>. <source>Mol. Psychiatry</source>
<volume>17</volume>:<fpage>946</fpage>&#x02013;<lpage>954</lpage>.<pub-id pub-id-type="pmid">22508465</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0021"><mixed-citation publication-type="journal" id="mgg3230-cit-0021">
<string-name>
<surname>Liu</surname>, <given-names>D. J.</given-names>
</string-name>, and <string-name>
<given-names>S. M.</given-names>
<surname>Leal</surname>
</string-name>. <year>2010a</year>
<article-title>A novel adaptive method for the analysis of next&#x02010;generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions</article-title>. <source>PLoS Genet.</source>
<volume>6</volume>:<fpage>e1001156</fpage>.<pub-id pub-id-type="pmid">20976247</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0022"><mixed-citation publication-type="journal" id="mgg3230-cit-0022">
<string-name>
<surname>Liu</surname>, <given-names>D. J.</given-names>
</string-name>, and <string-name>
<given-names>S. M.</given-names>
<surname>Leal</surname>
</string-name>. <year>2010b</year>
<article-title>Replication strategies for rare variant complex trait association studies via next&#x02010;generation sequencing</article-title>. <source>Am. J. Hum. Genet.</source>
<volume>87</volume>:<fpage>790</fpage>&#x02013;<lpage>801</lpage>.<pub-id pub-id-type="pmid">21129725</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0023"><mixed-citation publication-type="journal" id="mgg3230-cit-0023">
<string-name>
<surname>Martinez</surname>, <given-names>A. F.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Muenke</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Arcos&#x02010;Burgos</surname>
</string-name>. <year>2011</year>
<article-title>From the black widow spider to human behavior: latrophilins, a relatively unknown class of G protein&#x02010;coupled receptors, are implicated in psychiatric disorders</article-title>. <source>Am. J. Med. Genet. B Neuropsychiatr. Genet.</source>
<volume>156B</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">21184579</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0024"><mixed-citation publication-type="journal" id="mgg3230-cit-0024">
<string-name>
<surname>Molina</surname>, <given-names>B. S.</given-names>
</string-name>, and <string-name>
<given-names>W. E.</given-names>
<suffix>Jr</suffix>
<surname>Pelham</surname>
</string-name>. <year>2003</year>
<article-title>Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD</article-title>. <source>J. Abnorm. Psychol.</source>
<volume>112</volume>:<fpage>497</fpage>&#x02013;<lpage>507</lpage>.<pub-id pub-id-type="pmid">12943028</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0025"><mixed-citation publication-type="journal" id="mgg3230-cit-0025">
<string-name>
<surname>Molina</surname>, <given-names>B. S.</given-names>
</string-name>, <string-name>
<given-names>S. P.</given-names>
<surname>Hinshaw</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Swanson</surname>
</string-name>, <string-name>
<given-names>L. E.</given-names>
<surname>Arnold</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Vitiello</surname>
</string-name>, <string-name>
<given-names>P. S.</given-names>
<surname>Jensen</surname>
</string-name>, et&#x000a0;al. <year>2009</year>
<article-title>The MTA at 8&#x000a0;years: prospective follow&#x02010;up of children treated for combined&#x02010;type ADHD in a multisite study</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>48</volume>:<fpage>484</fpage>&#x02013;<lpage>500</lpage>.<pub-id pub-id-type="pmid">19318991</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0026"><mixed-citation publication-type="journal" id="mgg3230-cit-0026">
<string-name>
<surname>Molina</surname>, <given-names>B. S.</given-names>
</string-name>, <string-name>
<given-names>S. P.</given-names>
<surname>Hinshaw</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Eugene Arnold</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Swanson</surname>
</string-name>, <string-name>
<given-names>W. E.</given-names>
<surname>Pelham</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Hechtman</surname>
</string-name>, et&#x000a0;al. <year>2013</year>
<article-title>Adolescent substance use in the multimodal treatment study of attention&#x02010;deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>52</volume>:<fpage>250</fpage>&#x02013;<lpage>263</lpage>.<pub-id pub-id-type="pmid">23452682</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0027"><mixed-citation publication-type="journal" id="mgg3230-cit-0027">
<string-name>
<surname>O'Sullivan</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>de Wit</surname>
</string-name>, <string-name>
<given-names>J. N.</given-names>
<surname>Savas</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Comoletti</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Otto&#x02010;Hitt</surname>
</string-name>, <string-name>
<given-names>J. R.</given-names>
<suffix>3rd</suffix>
<surname>Yates</surname>
</string-name>, et&#x000a0;al. <year>2012</year>
<article-title>FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development</article-title>. <source>Neuron</source>
<volume>73</volume>:<fpage>903</fpage>&#x02013;<lpage>910</lpage>.<pub-id pub-id-type="pmid">22405201</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0028"><mixed-citation publication-type="journal" id="mgg3230-cit-0028">
<string-name>
<surname>Ribases</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Ramos&#x02010;Quiroga</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Sanchez&#x02010;Mora</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Bosch</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Richarte</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Palomar</surname>
</string-name>, et&#x000a0;al. <year>2011</year>
<article-title>Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study</article-title>. <source>Genes Brain Behav.</source>
<volume>10</volume>:<fpage>149</fpage>&#x02013;<lpage>157</lpage>.<pub-id pub-id-type="pmid">21040458</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0029"><mixed-citation publication-type="journal" id="mgg3230-cit-0029">
<string-name>
<surname>Segura</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<given-names>B. J.</given-names>
<surname>Vilhjalmsson</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Platt</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Korte</surname>
</string-name>, <string-name>
<given-names>U.</given-names>
<surname>Seren</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Long</surname>
</string-name>, et&#x000a0;al. <year>2012</year>
<article-title>An efficient multi&#x02010;locus mixed&#x02010;model approach for genome&#x02010;wide association studies in structured populations</article-title>. <source>Nat. Genet.</source>
<volume>44</volume>:<fpage>825</fpage>&#x02013;<lpage>830</lpage>.<pub-id pub-id-type="pmid">22706313</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0030"><mixed-citation publication-type="journal" id="mgg3230-cit-0030">
<collab collab-type="authors">The MTA Cooperative Group</collab>
. <year>1999</year>
<article-title>A 14&#x02010;month randomized clinical trial of treatment strategies for attention&#x02010;deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD</article-title>. <source>Arch. Gen. Psychiatry</source>
<volume>56</volume>:<fpage>1073</fpage>&#x02013;<lpage>1086</lpage>.<pub-id pub-id-type="pmid">10591283</pub-id></mixed-citation></ref><ref id="mgg3230-bib-0031"><mixed-citation publication-type="journal" id="mgg3230-cit-0031">
<string-name>
<surname>V&#x000e9;lez</surname>, <given-names>J. I.</given-names>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Correa</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Arcos&#x02010;Burgos</surname>
</string-name>. <year>2014</year>
<article-title>A new method for detecting significant p&#x02010;values with applications to genetic data</article-title>. <source>Rev. Colomb. Estadist.</source>
<volume>37</volume>:<fpage>67</fpage>&#x02013;<lpage>76</lpage>.</mixed-citation></ref><ref id="mgg3230-bib-0032"><mixed-citation publication-type="journal" id="mgg3230-cit-0032">
<string-name>
<surname>Wallis</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>D. S.</given-names>
<surname>Hill</surname>
</string-name>, <string-name>
<given-names>I. A.</given-names>
<surname>Mendez</surname>
</string-name>, <string-name>
<given-names>L. C.</given-names>
<surname>Abbott</surname>
</string-name>, <string-name>
<given-names>R. H.</given-names>
<surname>Finnell</surname>
</string-name>, <string-name>
<given-names>P. J.</given-names>
<surname>Wellman</surname>
</string-name>, et&#x000a0;al. <year>2012</year>
<article-title>Initial characterization of mice null for Lphn3, a gene implicated in ADHD and addiction</article-title>. <source>Brain Res.</source>
<volume>1463</volume>:<fpage>85</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">22575564</pub-id></mixed-citation></ref></ref-list></back></article>